TCM
SYRS

Tang Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Tang Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-85,031
Closed -$662K – 137
2023
Q4 		$662K Buy
+85,031
New +$662K 0.06% 110